Longevity Health (XAGE) Competitors $0.32 0.00 (0.00%) As of 11:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock XAGE vs. BBLG, BLAC, AMIX, PTHL, and PFSAShould you buy Longevity Health stock or one of its competitors? MarketBeat compares Longevity Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Longevity Health include Bone Biologics (BBLG), Bellevue Life Sciences Acquisition (BLAC), Autonomix Medical (AMIX), Pheton (PTHL), and Profusa (PFSA). These companies are all part of the "medical equipment" industry. XAGE vs. BBLGXAGE vs. BLACXAGE vs. AMIXXAGE vs. PTHLXAGE vs. PFSAHow does Longevity Health compare to Bone Biologics?Longevity Health (NASDAQ:XAGE) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Does the media prefer XAGE or BBLG? In the previous week, Bone Biologics had 7 more articles in the media than Longevity Health. MarketBeat recorded 7 mentions for Bone Biologics and 0 mentions for Longevity Health. Bone Biologics' average media sentiment score of 0.75 beat Longevity Health's score of 0.00 indicating that Bone Biologics is being referred to more favorably in the news media. Company Overall Sentiment Longevity Health Neutral Bone Biologics Positive Which has higher earnings and valuation, XAGE or BBLG? Bone Biologics has lower revenue, but higher earnings than Longevity Health. Bone Biologics is trading at a lower price-to-earnings ratio than Longevity Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongevity Health$1.05M0.54-$10.37M-$4.29N/ABone BiologicsN/AN/A-$3.11M-$2.27N/A Do analysts rate XAGE or BBLG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders and institutionals believe in XAGE or BBLG? 24.2% of Longevity Health shares are owned by institutional investors. Comparatively, 34.3% of Bone Biologics shares are owned by institutional investors. 29.0% of Longevity Health shares are owned by insiders. Comparatively, 6.1% of Bone Biologics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, XAGE or BBLG? Longevity Health has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Is XAGE or BBLG more profitable? Bone Biologics has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Longevity Health's return on equity of 0.00% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Longevity Health-682.67% N/A -261.90% Bone Biologics N/A -50.47%-47.40% SummaryBone Biologics beats Longevity Health on 9 of the 13 factors compared between the two stocks.How does Longevity Health compare to Bellevue Life Sciences Acquisition?Longevity Health (NASDAQ:XAGE) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap manufacturing companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability. Which has more volatility and risk, XAGE or BLAC? Longevity Health has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market. Do institutionals and insiders hold more shares of XAGE or BLAC? 24.2% of Longevity Health shares are owned by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. 29.0% of Longevity Health shares are owned by company insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is XAGE or BLAC more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets Longevity Health-682.67% N/A -261.90% Bellevue Life Sciences Acquisition N/A N/A N/A Which has stronger earnings & valuation, XAGE or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than Longevity Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongevity Health$1.05M0.54-$10.37M-$4.29N/ABellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Does the media prefer XAGE or BLAC? In the previous week, Longevity Health's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score. Company Overall Sentiment Longevity Health Neutral Bellevue Life Sciences Acquisition Neutral SummaryBellevue Life Sciences Acquisition beats Longevity Health on 4 of the 6 factors compared between the two stocks.How does Longevity Health compare to Autonomix Medical?Autonomix Medical (NASDAQ:AMIX) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation. Do analysts recommend AMIX or XAGE? Autonomix Medical presently has a consensus target price of $2.00, suggesting a potential upside of 401.25%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Autonomix Medical is more favorable than Longevity Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, AMIX or XAGE? Autonomix Medical has a beta of -1.82, meaning that its stock price is 282% less volatile than the broader market. Comparatively, Longevity Health has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Is AMIX or XAGE more profitable? Autonomix Medical has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Longevity Health's return on equity of 0.00% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -228.82% -186.65% Longevity Health -682.67%N/A -261.90% Which has preferable earnings and valuation, AMIX or XAGE? Longevity Health has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Longevity Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$11.41M-$3.55N/ALongevity Health$1.05M0.54-$10.37M-$4.29N/A Does the media prefer AMIX or XAGE? In the previous week, Autonomix Medical had 2 more articles in the media than Longevity Health. MarketBeat recorded 2 mentions for Autonomix Medical and 0 mentions for Longevity Health. Autonomix Medical's average media sentiment score of 0.00 equaled Longevity Health'saverage media sentiment score. Company Overall Sentiment Autonomix Medical Neutral Longevity Health Neutral Do institutionals and insiders have more ownership in AMIX or XAGE? 10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 29.0% of Longevity Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAutonomix Medical and Longevity Health tied by winning 7 of the 14 factors compared between the two stocks.How does Longevity Health compare to Pheton?Pheton (NASDAQ:PTHL) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends. Which has better earnings and valuation, PTHL or XAGE? Pheton has higher earnings, but lower revenue than Longevity Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPheton$305.22K6.21-$660KN/AN/ALongevity Health$1.05M0.54-$10.37M-$4.29N/A Which has more risk & volatility, PTHL or XAGE? Pheton has a beta of 5.4, meaning that its stock price is 440% more volatile than the broader market. Comparatively, Longevity Health has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Do insiders and institutionals have more ownership in PTHL or XAGE? 24.2% of Longevity Health shares are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is PTHL or XAGE more profitable? Pheton has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets PhetonN/A N/A N/A Longevity Health -682.67%N/A -261.90% Does the media favor PTHL or XAGE? In the previous week, Pheton's average media sentiment score of 0.00 equaled Longevity Health'saverage media sentiment score. Company Overall Sentiment Pheton Neutral Longevity Health Neutral Do analysts prefer PTHL or XAGE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryPheton beats Longevity Health on 6 of the 9 factors compared between the two stocks.How does Longevity Health compare to Profusa?Longevity Health (NASDAQ:XAGE) and Profusa (NASDAQ:PFSA) are both small-cap manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Is XAGE or PFSA more profitable? Profusa has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets Longevity Health-682.67% N/A -261.90% Profusa N/A N/A -1,348.07% Does the media prefer XAGE or PFSA? In the previous week, Profusa had 5 more articles in the media than Longevity Health. MarketBeat recorded 5 mentions for Profusa and 0 mentions for Longevity Health. Profusa's average media sentiment score of 0.22 beat Longevity Health's score of 0.00 indicating that Profusa is being referred to more favorably in the news media. Company Overall Sentiment Longevity Health Neutral Profusa Neutral Which has stronger earnings & valuation, XAGE or PFSA? Longevity Health has higher revenue and earnings than Profusa. Longevity Health is trading at a lower price-to-earnings ratio than Profusa, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongevity Health$1.05M0.54-$10.37M-$4.29N/AProfusa$100K17.25-$35.82M-$169.72N/A Which has more volatility & risk, XAGE or PFSA? Longevity Health has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Profusa has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market. Do institutionals & insiders hold more shares of XAGE or PFSA? 24.2% of Longevity Health shares are held by institutional investors. Comparatively, 9.8% of Profusa shares are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Comparatively, 11.4% of Profusa shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate XAGE or PFSA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Profusa 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryProfusa beats Longevity Health on 7 of the 13 factors compared between the two stocks. Get Longevity Health News Delivered to You Automatically Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAGE vs. The Competition ExportMetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$570K$3.16B$4.22B$12.29BDividend YieldN/AN/A6.21%5.32%P/E Ratio-0.070.9118.4922.73Price / Sales0.54393.10171.8677.74Price / CashN/A4.4053.8556.13Price / Book-0.053.2035.997.01Net Income-$10.37M-$76.79M$112.32M$335.05M7 Day PerformanceN/A1.73%-0.74%-0.29%1 Month Performance-4.42%-0.94%2.79%1.15%1 Year PerformanceN/A97.45%15.19%34.79% Longevity Health Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAGELongevity HealthN/A$0.32flatN/AN/A$570K$1.05MN/A14High Trading VolumeBBLGBone Biologics1.2008 of 5 stars$1.30+1.6%N/A-76.7%$2.34MN/AN/A2Earnings ReportAnalyst RevisionBLACBellevue Life Sciences AcquisitionN/A$0.57-0.5%N/A-54.9%$2.29MN/AN/AN/AGap UpHigh Trading VolumeAMIXAutonomix Medical1.9059 of 5 stars$0.33-1.6%$2.00+506.2%-81.2%$2.28MN/AN/A1Positive NewsAnalyst UpgradePTHLPhetonN/A$0.31-1.6%N/A-93.7%$2.05M$305.22KN/A11 Related Companies and Tools Related Companies Bone Biologics Alternatives Bellevue Life Sciences Acquisition Alternatives Autonomix Medical Alternatives Pheton Alternatives Profusa Alternatives Bluejay Diagnostics Alternatives GlucoTrack Alternatives Lyra Therapeutics Alternatives Strata Skin Sciences Alternatives Dynatronics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAGE) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
